We recently published a list of 10 Best Short-Term Stocks To Buy Right Now. In this article, we are going to take a look at ...

A research team investigates how genome editing can be harnessed to accelerate cassava breeding and improve key traits.

Cassava's strong liquidity with $128.6 million in cash supports early-stage development, yet long-term funding needs may lead to shareholder dilution. Learn more on SAVA stock here.

“Together, we will drive our ‘One Cassava’ strategy, which brings forward the full capability of the Cassava ecosystem in our chosen markets. This strategy enables us to serve our customers ...